From: Becker's Supply Chain Report <>
Subject: GSK taps 23andMe's DNA database for drug research | Netflix documentary reveals horror of medical device complications | AstraZeneca latest drugmaker to freeze 2018 price hikes | CMS' proposed outpatient payment rule: 10 things to know
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

July 27, 2018
1. AstraZeneca latest drugmaker to freeze 2018 price hikes             
2. 23andMe, GlaxoSmithKline join forces for genetic-based drug research Full story

3. Netflix documentary reveals horror of medical device complications Full story

4. The road to systemness: Delivering an outcomes-driven supply chain Learn more

5. CMS' proposed outpatient payment rule for 2019: 10 things to know Full story 

6. Gilead Sciences CEO to step down after nearly 3 decades   Full story
7. To gain insights into 3 overlooked components of high-performing healthcare facilities, download this free whitepaper.

8. Texas health system files for bankruptcy Full story
9. Washington county faces 57 opioids overdoses in 1 week   Full story
10. Mississippi hospital shuts down ER, unable to pay employees Full story
11. 40 CEOs and 10 presidents stepped into new roles in Q2 2018. Download this whitepaper to catch up on 116 hospital, health system executive moves. 

12. Endometriosis, malaria & leukemia treatments: 5 FDA approvals this week Full story

Contact Us

Editorial Contact: 
Molly Gamble 
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
Becker's Hospital Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by in collaboration with
Constant Contact